Sanofi to Acquire Principia Biopharma for ~$3.68B

Shots: Sanofi to acquire Principia Biopharma in an all-stock transaction, at $100/share making total deal value ~$3.68B in cash. The transaction is expected to be completed in Q4’20 The focus of the acquisition is to strengthen its R&D areas of autoimmune and allergic diseases with the expansion of the SAR442168 development program into CNS disorders. …

Sanofi to Acquire Principia Biopharma for ~$3.68B Read More »